Evidence map›Paper›PMID 42221976›Full record

ArticleRegenerative engineering and translational medicine2025

3D Printing of Enzymatically Softening Hydrogel Biomaterials.

Olivia P Dotson, Sherina Malkani, Inkyung Kang, Cole A DeForest, Kelly R Stevens

Abstract read
In one paragraph

Article in Regenerative engineering and translational medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Suspended Tissue Engineering with Assemblable Microfluidics (STEAM).bioRxiv : the preprint server for biology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Olivia P DotsonMolecular Engineering and Sciences Institute, University of Washington, Seattle, WA 98195, USA.
Sherina MalkaniInstitute for Stem Cell and Regenerative Medicine, Seattle, WA 98195, USA.
Inkyung KangInstitute for Stem Cell and Regenerative Medicine, Seattle, WA 98195, USA.
Cole A DeForestMolecular Engineering and Sciences Institute, University of Washington, Seattle, WA 98195, USA.
Kelly R StevensMolecular Engineering and Sciences Institute, University of Washington, Seattle, WA 98195, USA.ORCID 0000-0002-7503-7794

Funding

Photoabsorbing bioinks for expanding 3D printed human liver in situR01DK128551 · NIDDK · UNIVERSITY OF WASHINGTON · PI STEVENS, KELLY R · 2021 to 2024
$3.0M
Mimicking, Exploiting, and Understanding Biology's Heterogeneity in 4DR35GM138036 · NIGMS · UNIVERSITY OF WASHINGTON · PI Cole A DeForest · 2020 to 2026
$2.3M
On-Demand Modulation of Extracellular Matrix Mechanics for Studying RhoA Activation in Primary and Metastatic Colorectal CancerR21CA283686 · NCI · UNIVERSITY OF WASHINGTON · PI DEFOREST, COLE A, GRADY, WILLIAM MALLORY · 2024 to 2024
$428k
NCI NIH HHS R21 CA283686NIDDK NIH HHS R01 DK128551NIGMS NIH HHS R35 GM138036Wellcome Trust
6 · The paper itself

Abstract

Purpose: 3D printing has accelerated tissue engineering by enabling rapid fabrication of bioprinted tissues from a variety of soft biomaterials. Yet, an ongoing challenge is that for many bioprinting technologies, the materials (bioinks) need to be printed "stiff" (i.e., G' > ~ 15 kPa) so that the fabricated tissue constructs retain high resolution and shape fidelity. Conversely, softer materials tend to generally be more supportive of cellular phenotype and function. To bridge this gap, we sought to develop a hydrogel system that would expand bioprinting access to softer materials, while retaining the resolution of fabricated spatial features. Methods: We developed a photopolymerizable copolymer hydrogel system consisting of nondegradable synthetic and proteolytically degradable natural polymers. Varying the overall polymer content, as well as the ratio between the poly(ethylene glycol) and gelatin species, we generated a library of lithographically printable hydrogel formulations with differing initial stiffnesses that could be further variably softened following enzymatic treatment using collagenase. Results: Varying the copolymer composition and overall concentration resulted in the creation of gels whose initial stiffness ranged from 82 to 2 kPa and could be subsequently softened up to 20-fold upon enzymatic treatment. When 3D-printed via digital light processing (DLP), softened gels maintained higher structural integrity than those with matched initial stiffness. Softened gels supported greater endothelial cell perfusion-based seeding compared to those untreated while maintaining high cell viability. Conclusion: Our material system presents a simple solution to the ongoing challenge of 3D-printing soft materials with high resolution. Future Work: In future studies, we will develop post-print softening materials with bio-invisible stimuli to expand applications to in vivo softening of biomaterial tissue mimics. Lay Summary: 3D-printing has become popular in tissue engineering applications, but printing complex, organ-like structures with soft materials remains challenging. We created a material that can hold patterned shapes and small printed structures using a post-print softening technique with a degrading enzyme. We found that different formulations of this hydrogel material offer varying stiffness levels (G' = 2 kPa-82 kPa) and can soften up to 20-fold with enzymatic treatment. Notably, this material retains the structure of 3D-printed open channels even after significant softening, and cells respond well when seeded in these channels. This demonstrates the promise of post-print softening to create soft 3D-printed materials.

Indexed as

3D-printingBiomaterialsHydrogelTissue engineering

Identifiers

PMID42221976
PMCPMC13221206

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.